A new AF atrial fibrillation (AF) patient survey carried out by the AF Association has been launched. Results showed that 79% of patients surveyed—who are currently on a vitamin K antagonist such as warfarin—said that they would favour the “a life free from frequent clinic visits” that patient self-monitoring (PSM)’s could allow, according to a press release.

The survey launch coincides with the launch of the next generation of international normalised ratio PSM meter for patients. New meters allow patients to send their results to their clinic via an app on their phone using wireless connectivity.

Trudie Lobban, founder and chief executive officer of the AF Association, says “The results of the survey showed that nearly 80% of patients would want to self-monitor, giving them independence when travelling for work or pleasure. This innovation helps to empower patients to take control of their therapy and reduce the number of clinic visits that they have to make, saving both time and money”.